Cargando…

Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence

SARS-Cov-2 infection, a pandemic disease since March 2020, is associated with a high percentage of cardiovascular complications mainly of a thromboembolic (TE) nature. Although clinical patterns have been described for the assessment of patients with increased risk, many TE complications occur in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palazzuoli, Alberto, Giustozzi, Michela, Ruocco, Gaetano, Tramonte, Francesco, Gronda, Edoardo, Agnelli, Giancarlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145351/ https://www.ncbi.nlm.nih.gov/pubmed/33925334 http://dx.doi.org/10.3390/life11050395

Ejemplares similares

Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management
por: Giustozzi, Michela, et al.
Publicado: (2020)

Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

Recent advances in pharmacological treatment of heart failure
por: Iacoviello, Massimo, et al.
Publicado: (2021)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study
por: Giustozzi, Michela, et al.
Publicado: (2021)

Clinical, Laboratory and Lung Ultrasound Assessment of Congestion in Patients with Acute Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2022)

Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

In-hospital Routes of Acute Heart Failure Admissions During COVID-19
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020)

DOACs in patients with brain cancers: promising but still a long way to go
por: Giustozzi, Michela, et al.
Publicado: (2022)

Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe?
por: Gronda, Edoardo, et al.
Publicado: (2023)

ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis
por: Giustozzi, Michela, et al.
Publicado: (2022)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2020)

Risk Factors and Cellular Differences in Heart Failure: The Key Role of Sex Hormones
por: Delcuratolo, Elvira, et al.
Publicado: (2023)

The use of diuretics in heart failure with congestion: we can't judge a book by its cover
por: Palazzuoli, Alberto, et al.
Publicado: (2019)

Pulmonary Artery Systolic Pressure and Cava Vein Status in Acute Heart Failure with Preserved Ejection Fraction: Clinical and Prognostic Implications
por: Ruocco, Gaetano, et al.
Publicado: (2023)

Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
por: Palazzuoli, Alberto, et al.
Publicado: (2013)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Acute venous thromboembolism in patients with brain cancer: clinical course
por: Becattini, Cecilia, et al.
Publicado: (2023)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Non-invasive assessment of acute heart failure by Stevenson classification: Does echocardiographic examination recognize different phenotypes?
por: Palazzuoli, Alberto, et al.
Publicado: (2022)

Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients
por: Becattini, Cecilia, et al.
Publicado: (2020)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
por: Palazzuoli, Alberto, et al.
Publicado: (2022)

Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2020)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
por: Feola, Mauro, et al.
Publicado: (2020)

Correction: Feola, M., et al. Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation. J. Clin. Med. 2020, 9, 2932
por: Feola, Mauro, et al.
Publicado: (2021)

Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options
por: Ay, Cihan, et al.
Publicado: (2017)

Thromboembolic complications in COVID-19 clinical case
por: Capisizu, A., et al.
Publicado: (2022)

Acute Coronary Syndromes: From The Laboratory Markers To The Coronary Vessels
por: Alberto, Palazzuoli, et al.
Publicado: (2007)

A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report
por: Takeuchi, Takaya, et al.
Publicado: (2021)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
por: Palazzuoli, Alberto, et al.
Publicado: (2014)

Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications
por: Vannuccini, Francesca, et al.
Publicado: (2022)

Thromboembolic complications of COVID-19
por: Mui, Leonora W., et al.
Publicado: (2020)

The management of acute venous thromboembolism in clinical practice: Results from the European PREFER in VTE Registry
por: Cohen, Alexander T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a8mp4be2ur8dq33lg06c6da38e